Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Other financing activities (2021 - 2022)

Rani Therapeutics Holdings (RANI) has 2 years of Other financing activities data on record, last reported at $152000.0 in Q4 2022.

  • For Q4 2022, Other financing activities changed N/A year-over-year to $152000.0; the TTM value through Dec 2022 reached $260000.0, changed N/A, while the annual FY2022 figure was $260000.0, N/A changed from the prior year.
  • Other financing activities reached $152000.0 in Q4 2022 per RANI's latest filing, up from $108000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $2.2 million in Q2 2021 and bottomed at -$1.9 million in Q3 2021.